Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Free Cash Flow (2020 - 2025)

NeuroPace has reported Free Cash Flow over the past 6 years, most recently at $163000.0 for Q4 2025.

  • Quarterly results put Free Cash Flow at $163000.0 for Q4 2025, up 103.4% from a year ago — trailing twelve months through Dec 2025 was -$11.3 million (up 37.89% YoY), and the annual figure for FY2025 was -$11.3 million, up 37.89%.
  • Free Cash Flow for Q4 2025 was $163000.0 at NeuroPace, up from -$1.7 million in the prior quarter.
  • Over the last five years, Free Cash Flow for NPCE hit a ceiling of $163000.0 in Q4 2025 and a floor of -$11.4 million in Q1 2022.
  • Median Free Cash Flow over the past 5 years was -$5.4 million (2021), compared with a mean of -$5.6 million.
  • Biggest five-year swings in Free Cash Flow: plummeted 92.45% in 2022 and later soared 103.4% in 2025.
  • NeuroPace's Free Cash Flow stood at -$8.4 million in 2021, then rose by 4.34% to -$8.0 million in 2022, then soared by 59.61% to -$3.2 million in 2023, then tumbled by 48.28% to -$4.8 million in 2024, then soared by 103.4% to $163000.0 in 2025.
  • The last three reported values for Free Cash Flow were $163000.0 (Q4 2025), -$1.7 million (Q3 2025), and -$2.2 million (Q2 2025) per Business Quant data.